Outcome domains reported in calcium pyrophosphate deposition studies: A scoping review by the OMERACT CPPD working group
- 1 August 2020
- journal article
- review article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 50 (4) , 719-727
Abstract
No abstract availableKeywords
Funding Information
- Arthritis Australia
This publication has 33 references indexed in Scilit:
- Efficacy of anakinra for refractory acute calcium pyrophosphate crystal arthritisJoint Bone Spine, 2012
- Developing core outcome sets for clinical trials: issues to considerTrials, 2012
- European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosisAnnals of the Rheumatic Diseases, 2011
- Outcome Domains for Studies of Acute and Chronic GoutThe Journal of Rheumatology, 2009
- Calcium pyrophosphate dihydrate crystal deposition in the craniovertebral junctionJournal of Neurosurgery: Spine, 2008
- Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: An exploratory analysisArthritis & Rheumatism, 2007
- Photobiomodulation of Pain and Inflammation in Microcrystalline Arthropathies: Experimental and Clinical ResultsPhotomedicine and Laser Surgery, 2006
- PYROPHOSPHATE ARTHROPATHY: A PROSPECTIVE STUDYRheumatology, 1993
- Crystal shedding and acute pseudogout. An hypothesis based on a therapeutic failureArthritis & Rheumatism, 1976
- Chondrocalcinosis ArticularisAnnals of the Rheumatic Diseases, 1963